New Study Reveals Widespread Concern over Prescription Price Controls, Costs, and Access
86 percent of respondents shared concerns that state-run Prescription Drug Affordability Boards (PDABs) will limit treatment options; 51 percent said medicines prescribed by their doctor were denied by their insurer
NPLB Gets Animated: Roadmap to Patient Affordability and Innovation
Insurance Reform Needed to Cover Prescribed Medicines without High Out-of-Pocket Costs
“Abbie” Video Highlights Need for Insurance Reforms that Lower Out-of-Pocket Costs
“If a doctor prescribes a treatment and the insurer authorizes it, the copay should be affordable.”
We’re building support across the biotech ecosystem
BECOME A FIRST RESPONDER & THOUGHT PARTNER
Sign up to receive action alerts. Help protect access to lifesaving medicines & preserve innovation for those still waiting for a cure.